Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Neurocrine Biosciences Inc Transaction History
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
- $826 Billion
- Q4 2024
A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 53,954 shares of NBIX stock, worth $5.78 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
53,954
Previous 247,043
78.16%
Holding current value
$5.78 Million
Previous $28.5 Billion
74.13%
% of portfolio
0.89%
Previous 3.95%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.52 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.09 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$524 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$323 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$272 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...